All
Kadcyla (T-DM1) approved to treat HER2+ breast cancer
Robin Roberts Returns to Good Morning America
Robin Roberts, who was one of the most influential people in cancer last year, returns to "Good Morning America" today after recovering from MDS and a bone marrow transplantation.
Personalized medicine and what it means
Upcoming meetings will bring patients and survivors together:Are you attending?
Pomalyst approved to treat multiple myeloma
Should Breast Cancer in Young Women Be Treated Differently?
While breast cancer in young women appears to have similar characteristics, many experts agree that treating the type of breast cancer is more important than focusing on age at this point.
Abraxane combo extends survival in advanced pancreatic cancer
Study highlights gains in pancreatic cancer, but will it help U.S. patients?
Avastin: new indication for colorectal cancer treatment
Facebook Chat recap: Lifestyle changes to improve well-being and reduce recurrence
Help the economy: stop smoking
Small gains in pancreatic and gastric cancers add up
Being frank about sex: How I reclaimed my lady parts after cervical cancer
Fitness facts for cancer survivors
There will be love
Finding support
Want to learn more about cervical cancer?
Thank an oncology nurse today
There are things people dislike more than colonoscopies
Report to the nation on cancer shows mortality drops, HPV-related cancers on the rise
Help Wanted: What if I Can't Pay for My Cancer Care?
Cost of cancer care is a growing concern of both patients and medical professionals.
Targeted Therapy for Certain Leukemias Continues to Impress in Phase 2 Trial
Ponatinib continues to make improvements in phase 2 CML study.
Velcade-based Therapy Shows Benefit in Multiple Myeloma
Velcade-based therapy shows benefit in multiple myeloma trial called GIMEMA.
Moving Away from Chemo in Acute Promyelocytic Leukemia
A study shows that a chemotherapy-free regimen may be better in acute promyelocytic leukemia.
Targeted therapy for certain leukemias receives FDA approval ahead of schedule
Medicare Resources
Find information and resources on Medicare.
Learning about CML
One year of Herceptin optimal for HER2-positive breast cancer
When people want to help, say yes
Moving away from chemo in acute promyelocytic leukemia
